Literature DB >> 3109607

Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry.

F Al-Azzawi, D M Hart, R Lindsay.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 3109607      PMCID: PMC1246431          DOI: 10.1136/bmj.294.6582.1261-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Prevention of spinal osteoporosis in oophorectomised women.

Authors:  R Lindsay; D M Hart; C Forrest; C Baird
Journal:  Lancet       Date:  1980-11-29       Impact factor: 79.321

2.  Radiological determination of changes in bone mineral content.

Authors:  R Lindsay; J B Anderson
Journal:  Radiography       Date:  1978-01

3.  Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.

Authors:  R Lindsay; D M Hart; J M Aitken; E B MacDonald; J B Anderson; A C Clarke
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

4.  Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis.

Authors:  B L Riggs; H W Wahner; W L Dunn; R B Mazess; K P Offord; L J Melton
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

  4 in total
  7 in total

Review 1.  Hormone replacement therapy in the aged. A state of the art review.

Authors:  S Jacobs; T C Hillard
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

2.  Femoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen.

Authors:  B Kristensen; B Ejlertsen; H T Mouridsen; K W Andersen; J B Lauritzen
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 3.  Estrogen: effects and actions in osteoporosis.

Authors:  R Lindsay; F Cosman; J Nieves
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

4.  Targeted estrogen/progesterone replacement therapy for osteoporosis: calculation of health care cost savings.

Authors:  A P Clark; J A Schuttinga
Journal:  Osteoporos Int       Date:  1992-07       Impact factor: 4.507

5.  Salmon calcitonin nasal spray : An effective alternative to estrogen therapy in select postmenopausal women.

Authors:  L V Avioli
Journal:  Endocrine       Date:  1996-10       Impact factor: 3.633

6.  Changing incidence and residual lifetime risk of common osteoporosis-related fractures.

Authors:  J B Lauritzen; P Schwarz; B Lund; P McNair; I Transbøl
Journal:  Osteoporos Int       Date:  1993-05       Impact factor: 4.507

Review 7.  Hormones and bone health in postmenopausal women.

Authors:  Robert Lindsay
Journal:  Endocrine       Date:  2004-08       Impact factor: 3.633

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.